As models scale and clusters swell, light is taking over the job of moving bits. From 800G pluggables to co-packaged optics, the race is on to deliver more bandwidth per watt—and the winners will be those who can make photons flow with the least power and the least friction.
AI inference has turned data centers into industrial-scale factories, built on dense accelerators, high-bandwidth memory, liquid cooling and optical fabrics. The race to serve tokens efficiently is reshaping supply chains from GPUs to fiber switches.
China’s chip-equipment champions are moving from state-funded experiments to real contenders.
Scale, software and data—not price—now decide who wins in payment processing. Giants like Fiserv, Global Payments and Adyen stitch cards, wallets and bank rails into one brain, lifting approvals and shaving fraud while embedding themselves in merchants’ operating systems.
The networks solve a wicked coordination problem. They give every merchant a way to accept every card from every bank, in every country, with one contract and one technical spec. Replicating that means persuading millions of merchants and tens of thousands of issuers to adopt the same rules
The Global Payment Ecosystem: Visa and Mastercard mint margins as toll roads; fintechs add slick apps but face thinner take rates and fierce competition.
The race to master Gate-All-Around technology marks the semiconductor industry's entry into a new era of atomic-scale manufacturing.
Five firms still dominate hearing aids, but OTC devices, Apple’s earbuds, and Essilor’s hearing glasses are reshaping the entry tier. Aging boosts volume; the moat endures—but growth hinges on upgrading “good-enough” users to premium care.
The digital arms race is intensifying. Organizations now spend roughly $200 billion a year on security products and services (McKinsey), up from about $140 billion in 2020, and industry forecasters project ~12–13% annual growth through 2027. A big share (around 65%) of cyber budgets goes to outside vendors, giving
When the house itself is on the market, investors can buy a toll‑booth that never sleeps.
Why Western governments are rethinking rock‑bottom drug prices in a world no longer sure of its supply chains
The $100 genome is here, but growth stalls: regulation, reimbursement and China’s price war reshape a crowded sequencing market racing toward multi‑omics.
Showing 12 of 15 total posts
Stay up to date with curated collection of our top stories.
